Editas And Allergan Launch World’s First In Vivo CRISPR Trial
Rare Blindness Targeted
Partners pioneer approach in rare disease in what will be pivotal year for CRISPR and gene-editing technologies.
Partners pioneer approach in rare disease in what will be pivotal year for CRISPR and gene-editing technologies.